These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33862168)

  • 1. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
    Kooijmans SAA; de Jong OG; Schiffelers RM
    Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
    Moloudizargari M; Asghari MH; Goel A
    Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.
    Oshchepkova A; Zenkova M; Vlassov V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases.
    Su Y; Chen M; Xu W; Gu P; Fan X
    ACS Nano; 2024 Aug; 18(34):22793-22828. PubMed ID: 39141830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability.
    Piffoux M; Volatron J; Cherukula K; Aubertin K; Wilhelm C; Silva AKA; Gazeau F
    Adv Drug Deliv Rev; 2021 Nov; 178():113972. PubMed ID: 34509573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic design of extracellular vesicle drug delivery systems.
    Armstrong JPK; Stevens MM
    Adv Drug Deliv Rev; 2018 May; 130():12-16. PubMed ID: 29959959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
    Lamichhane TN; Jay SM
    Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.
    Armstrong JP; Holme MN; Stevens MM
    ACS Nano; 2017 Jan; 11(1):69-83. PubMed ID: 28068069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.